Modern Pathology
-
Publication Venue For
- Chrysotile fibers in tissue adjacent to laryngeal squamous cell carcinoma in cases with a history of occupational asbestos exposure. 2019
- Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature. 2019
- PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.. 32:741-754. 2019
- T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers.. 32:576-584. 2019
- CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.. 31:718-731. 2018
- Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.. 31:598-606. 2018
- Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.. 30:1760-1772. 2017
- FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.. 30:1262-1272. 2017
- Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.. 30:761-772. 2017
- #InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of Pathology.. 30:160-168. 2017
- Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.. 29:1143-1154. 2016
- Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.. 29:832-843. 2016
- Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.. 29:893-903. 2016
- Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.. 28:654-661. 2015
- Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.. 28:428-436. 2015
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.. 27:271-280. 2014
- Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findings.. 26:166-170. 2013
- Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.. 25:1574-1583. 2012
- Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.. 24:1221-1228. 2011
- ERG-TMPRSS2 Rearrangement is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Further Evidence Supporting Monoclonal Origin. 24:1120-1127. 2011
- Working group 2: T2 substaging and prostate cancer volume. 16-25. 2011
- Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. 26-38. 2011
- Working group 4: seminal vesicles and lymph nodes. 39-47. 2011
- Working group 5: surgical margins. 48-57. 2011
- Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.. 23:470-479. 2010
- Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma.. 23:134-143. 2010
- Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.. 21:1084-1094. 2008
- Expression of p14(ARF), p15(INK4b), p16(INK4a), and DCR2 increases during prostate cancer progression. 19:1339-1343. 2006
- Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ. 2019
- The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. 2016
- Working group 1: specimen handling 2011